Globus Medical plans to buy spinal cord stimulation company Nevro ... acquisition may surprise investors as Globus had just bought Nuvasive for $3.1 billion in 2023. “We don’t believe ...

Nevro's high-frequency neurostimulation cuts diabetic neuropathy pain by 80% in 2-year study Globus aims to add Nevro’s portfolio—with its spinal cord ... specialist NuVasive, with the goal ...

The synergies from its merger with NuVasive run high ... Through the past few quarters, Globus Medical has registered above-market growth in the U.S. spine business, driven by combined product ...

These systems integrate artificial intelligence (AI), real-time imaging, and navigation technology to assist surgeons in performing minimally invasive spinal procedures. Companies like Medtronic and ...

In the first quarter of 2022, SMAIO and NuVasive, a global leader in spine technology innovation ... On September 1 st, 2023, NuVasive was acquired by Globus Medical, a U.S.-based company specialized ...

On September 1 st, 2023, NuVasive was acquired by Globus Medical ... intend to position SMAIO as an international leader in the spinal realignment market and generate sustained growth over ...

A lumbar puncture (spinal tap) is a common test doctors use to check for signs of MS in your spinal fluid. But a lumbar puncture on its own isn’t enough to confirm an MS diagnosis. Diagnosing ...

leading Globus Medical’s acquisition of NuVasive, Inc. and integrating the two organizations to create the second largest spine technology company in the world. Prior to that, Mr. Scavilla held ...

having successfully led the merger of Globus and NuVasive. Mr. Barber will be joining the Board’s Science and Technology Committee and Mr. Scavilla will be joining the Board’s Audit and Finance ...